These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27470368)

  • 1. HMGA1 facilitates tumor progression through regulating Wnt/β-catenin pathway in endometrial cancer.
    Han X; Cao Y; Wang K; Zhu G
    Biomed Pharmacother; 2016 Aug; 82():312-8. PubMed ID: 27470368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of NEAT1/miR-214-3p on the growth, migration and invasion of endometrial carcinoma cells.
    Wang J; Zhao X; Guo Z; Ma X; Song Y; Guo Y
    Arch Gynecol Obstet; 2017 Jun; 295(6):1469-1475. PubMed ID: 28447190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
    Chen H; Wang Y; Xue F
    Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA1 interacts with β-catenin to positively regulate Wnt/β-catenin signaling in colorectal cancer cells.
    Xing J; Cao G; Fu C
    Pathol Oncol Res; 2014 Oct; 20(4):847-51. PubMed ID: 24696416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells.
    Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
    Cell Biochem Funct; 2017 Oct; 35(7):464-471. PubMed ID: 29023799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
    Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
    Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGA1 is induced by Wnt/beta-catenin pathway and maintains cell proliferation in gastric cancer.
    Akaboshi S; Watanabe S; Hino Y; Sekita Y; Xi Y; Araki K; Yamamura K; Oshima M; Ito T; Baba H; Nakao M
    Am J Pathol; 2009 Oct; 175(4):1675-85. PubMed ID: 19729480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpressing of POU2F2 accelerates fracture healing via regulating HMGA1/Wnt/β-catenin signaling pathway.
    Zhang W; Zhao H; Chen K; Huang Y
    Biosci Biotechnol Biochem; 2020 Mar; 84(3):491-499. PubMed ID: 31782345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NRF1-regulated CircNSUN2 promotes lymphoma progression through activating Wnt signaling pathway via stabilizing HMGA1.
    Wang L; Yang B; Xu Z; Song X; Gong Z; Xue S; Kong L
    Cell Cycle; 2021 May; 20(9):819-828. PubMed ID: 33858292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA steroid receptor activator promotes the progression of endometrial cancer via Wnt/ β-catenin signaling pathway.
    Park SA; Kim LK; Kim YT; Heo TH; Kim HJ
    Int J Biol Sci; 2020; 16(1):99-115. PubMed ID: 31892849
    [No Abstract]   [Full Text] [Related]  

  • 11. MicroRNA-202 inhibits cell migration and invasion through targeting FGF2 and inactivating Wnt/β-catenin signaling in endometrial carcinoma.
    Chen P; Xing T; Wang Q; Liu A; Liu H; Hu Y; Ji Y; Song Y; Wang D
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31533968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.
    Fu F; Wang T; Wu Z; Feng Y; Wang W; Zhou S; Ma X; Wang S
    Cell Death Dis; 2018 May; 9(6):594. PubMed ID: 29789601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting Wnt/beta-catenin in CTNNB1-mutated endometrial cancer.
    Moroney MR; Woodruff E; Qamar L; Bradford AP; Wolsky R; Bitler BG; Corr BR
    Mol Carcinog; 2021 Aug; 60(8):511-523. PubMed ID: 34038589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT.
    Chang X; Liu J; Yang Q; Gao Y; Ding X; Zhao J; Li Y; Liu Z; Li Z; Wu Y; Zuo D
    Biochem Pharmacol; 2023 Jun; 212():115582. PubMed ID: 37146833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between S100A13 and HMGA1 in the modulation of thyroid cancer proliferation and invasion.
    Zhong J; Liu C; Chen YJ; Zhang QH; Yang J; Kang X; Chen SR; Wen GB; Zu XY; Cao RX
    J Transl Med; 2016 Mar; 14():80. PubMed ID: 27008379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.
    Hillion J; Roy S; Heydarian M; Cope L; Xian L; Koo M; Luo LZ; Kellyn K; Ronnett BM; Huso T; Armstrong D; Reddy K; Huso DL; Resar LMS
    Gynecol Oncol; 2016 Jun; 141(3):580-587. PubMed ID: 27001612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in Wnt-β-catenin and Pten signalling play distinct roles in endometrial cancer initiation and progression.
    van der Zee M; Jia Y; Wang Y; Heijmans-Antonissen C; Ewing PC; Franken P; DeMayo FJ; Lydon JP; Burger CW; Fodde R; Blok LJ
    J Pathol; 2013 May; 230(1):48-58. PubMed ID: 23288720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated glucose levels impair the WNT/β-catenin pathway via the activation of the hexosamine biosynthesis pathway in endometrial cancer.
    Zhou F; Huo J; Liu Y; Liu H; Liu G; Chen Y; Chen B
    J Steroid Biochem Mol Biol; 2016 May; 159():19-25. PubMed ID: 26923859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression.
    Cao XP; Cao Y; Zhao H; Yin J; Hou P
    Biochem Biophys Res Commun; 2019 Aug; 516(2):457-465. PubMed ID: 31229266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.